BPTS - Biophytis down 12% on $3.8M offering
2023-07-19 06:34:45 ET
- Clinical-stage biotechnology company, Biophytis ( NASDAQ: BPTS ) stock price jumps 13% as the company enters purchase and sale of 1.33M units , each consisting of one ADS or one prefunded warrant giving right to one ADS.
- Each ADS represents the right to receive one hundred new ordinary shares, nominal value €0.01 per share, of the company.
- The closing of the offering is expected to occur on or about July 21, 2023.
- The gross are expected to be ~$3.8M.
- Net proceeds for funding research and development and clinical trials and for other working capital and general corporate purposes.
For further details see:
Biophytis down 12% on $3.8M offering